Lord Abbett Micro Cap Growth F (LFMGX)
| Fund Assets | 197.91M |
| Expense Ratio | 1.13% |
| Min. Investment | $1,500 |
| Turnover | 122.00% |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Dividend Growth | n/a |
| Payout Frequency | n/a |
| Ex-Dividend Date | n/a |
| Previous Close | 24.36 |
| YTD Return | 11.79% |
| 1-Year Return | 20.06% |
| 5-Year Return | 71.62% |
| 52-Week Low | 16.02 |
| 52-Week High | 25.02 |
| Beta (5Y) | n/a |
| Holdings | 73 |
| Inception Date | Aug 28, 2020 |
About LFMGX
The Lord Abbett Micro Cap Growth Fund Class F is a mutual fund specializing in the pursuit of long-term capital appreciation through investments in U.S. micro-cap and small-cap companies. The fund primarily allocates at least 80% of its net assets to equity securities of firms with market capitalizations under $350 million at the time of purchase, targeting enterprises with the potential for rapid growth relative to the broader economy. This strategic focus supports exposure to diverse sectors, including health care, industrials, consumer discretionary, and information technology, reflecting the wide-ranging opportunities within the micro-cap segment. With a portfolio of approximately 73 holdings, the fund emphasizes bottom-up security selection to uncover innovative and emerging growth businesses. Featuring an annual dividend distribution and a net expense ratio of 1.13%, the fund provides investors access to a dynamic segment of the equity market that can offer significant growth prospects, albeit with higher risk and volatility compared to larger-cap investments. Since its inception in August 2020, the fund has played a specialized role for those seeking exposure to early-stage U.S. growth companies within the financial markets.
Performance
LFMGX had a total return of 20.06% in the past year, including dividends. Since the fund's inception, the average annual return has been 12.82%.
Top 10 Holdings
26.63% of assets| Name | Symbol | Weight |
|---|---|---|
| Mirum Pharmaceuticals, Inc. | MIRM | 3.54% |
| Life360, Inc. | LIF | 2.93% |
| Paymentus Holdings, Inc. | PAY | 2.86% |
| Tarsus Pharmaceuticals, Inc. | TARS | 2.81% |
| Argan, Inc. | AGX | 2.69% |
| Artivion, Inc. | AORT | 2.61% |
| Rhythm Pharmaceuticals, Inc. | RYTM | 2.45% |
| GeneDx Holdings Corp. | WGS | 2.41% |
| Adaptive Biotechnologies Corporation | ADPT | 2.18% |
| Primoris Services Corporation | PRIM | 2.16% |